Related Experiment Videos
Progress in the pathogenesis of amyotrophic lateral sclerosis
C E Shaw1, A al-Chalabi, N Leigh
1Department of Neurology, Guy's, King's, and St. Thomas' School of Medicine, Institute of Psychiatry, De Crespigny Park, London SE5 8AS, United Kingdom. chris.shaw@iop.kcl.ac.uk
Current Neurology and Neuroscience Reports
|March 20, 2002
Summary
Amyotrophic lateral sclerosis (ALS) research has identified mutations in the copper/zinc superoxide dismutase (SOD1) gene as a cause. Understanding mutant SOD1 toxicity and other factors is crucial for developing effective ALS treatments and prevention strategies.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
- Mutations in the copper/zinc superoxide dismutase (SOD1) gene are a known cause of familial ALS.
- Understanding the molecular mechanisms underlying neuronal death in ALS is critical.
Purpose of the Study:
- To review recent advances in amyotrophic lateral sclerosis (ALS) research.
- To explore the biochemical pathways disturbed by mutant SOD1.
- To critically evaluate various proposed mechanisms of neuronal death in ALS.
Main Methods:
- Literature review of recent ALS research.
- Analysis of evidence for various etiological factors.
- Discussion of diagnostic challenges and genetic discoveries.
Main Results:
- Mutant SOD1 serves as a key tool for studying ALS pathogenesis.
- Multiple potential pathways contribute to neuronal dysfunction, including excitotoxicity, oxidative stress, and mitochondrial dysfunction.
- No single consensus pathway explains neuronal death in most ALS cases.
Conclusions:
- The precise pathways leading to selective neuronal death in ALS remain largely unknown.
- Identifying genetic susceptibility and environmental triggers is essential for developing effective ALS treatments.
- The ultimate goal of ALS research is prevention.